Micro-x Ltd. · ASX:MX1
Micro-x — Shareholder Meeting (November 2020)
36 slides from Micro-x's shareholder meeting presentation, Nov 18, 2020
Slide 1: 2020 Annual General Meeting
ACN 153 273 735 For personal use only ASX: MX1 Ltd ACN 153 273 735 ASX: MX1 ACN 153 273 735 ASX: MX1 2020 Annual General Meeting 10.00am (Adelaide time) Virtual Conference 15th15th April April 20202020 Peter Peter Rowland Rowland Managing Managing Director Director & CEO & CEO 18 November 2020 18/11
Slide 2: Agenda
Agenda For personal use only • Open Meeting • Chairman’s address • AGM Resolutions • CEO’s Presentation • Tube Manufacturing Facility Virtual Tour • Question and Answer • Close Meeting Conference Annual General Meeting will be held virtually on the online platform, Zoom webinar at https://us02web.zo
Slide 3: Chairman's Address
For personal use only Chairman’s Address © Micro-X Ltd – Annual General Meeting - 18 November 2020 3
Slide 4: Ordinary Business: Items of Business
Ordinary Business For personal use only Items of Business • 2020 Financial Statements and Reports • Resolution 1 – Adoption of Remuneration Report • Resolution 2 – Re-election of Patrick O’Brien as a Director • Resolution 3 – Re-election of David Knox as a Director • Resolution 4 – Ratification of I
Slide 5: 2020 Financial Statements and Reports
Ordinary Business For personal use only 2020 Financial Statements and Reports While not a a requirement that shareholders vote in relation to the accounts, we are pleased to answer any questions you may have relating to them. © Micro-X Ltd – Annual General Meeting - 18 November 2020 5
Slide 6: Resolution: Adoption of Remuneration Report
Ordinary Business For personal use only RESOLUTION 1 – Adoption of Remuneration Report To consider and, if thought fit, to pass the following resolution as an ordinary resolution: “That for the purpose of Section 250R(2) of the Corporations Act and for all other purposes, the Remuneration Report (in
Slide 7: Resolution: Re-election of Mr Patrick O'Brien
Ordinary Business For personal use only RESOLUTION 2 – Re-election of Mr Patrick O’Brien as a Director of the Company To consider and, if thought fit, pass the following resolution as an ordinary resolution: “That Mr Patrick O’Brien, being a Director who retires pursuant to the Constitution of the C
Slide 8: Resolution: Re-election of Mr David Knox
Ordinary Business For personal use only RESOLUTION 3 – Re-election of Mr David Knox as a Director of the Company To consider and, if thought fit, pass the following resolution as an ordinary resolution: “That Mr David Knox, being a Director who was appointed by the Company's directors on 7 April 202
Slide 9: Resolution: Ratification of issue of the Placement Shares
Ordinary Business For personal use only RESOLUTION 4 – Ratification of issue of the Placement Shares To consider and, if thought fit, pass the following resolution as an ordinary resolution: “That, for the purposes of ASX Listing Rule 7.4 and for all other purposes, Shareholders ratify the issue of
Slide 10: Resolution: Approval of Employee Incentive Plan
Ordinary Business For personal use only RESOLUTION 5 – Approval of Employee Incentive Plan To consider and, if thought fit, pass the following resolution as an ordinary resolution: “That, for the purposes of ASX Listing Rule 7.2 (Exception 13) and for all other purposes, Shareholders approve the Emp
Slide 11: Resolution: Performance and Service Rights to Mr Peter Rowland
Ordinary Business For personal use only RESOLUTION 6 – Approval of issue of Performance Rights and Service Rights to Mr Peter Rowland under the Employee Equity Plan To consider and, if thought fit, pass the following resolution as an ordinary resolution: “That, for the purposes of ASX Listing Rule 1
Slide 12: Resolution: Approval of 10% Placement Capacity
Ordinary Business For personal use only RESOLUTION 7 – Approval of 10% Placement Capacity To consider and, if thought fit, pass the following resolution as an ordinary resolution: “That, pursuant to and in accordance with ASX Listing Rule 7.1A and for all other purposes, Shareholders approve the iss
Slide 13: Agenda
Agenda For personal use only • Open Meeting • Chairman’s address • AGM Resolutions • CEO’s Presentation • Tube Manufacturing Facility Virtual Tour • Question and Answer • Close Meeting Conference Annual General Meeting will be held virtually on the online platform, Zoom webinar at https://us02web.zo
Slide 14: CEO Presentation
ACN 153 273 735 For personal use only ASX: MX1 Ltd Ltd ACN 153 273 735 ASX: MX1 ACN 153 273 735 ASX: MX1 To Update with new CEO Presentation graphics CEO Company Presentation Presentation Fundingsales Building strategic growth of next initiativesx-ray generation to drive sales Fast becoming a commer
Slide 15: Disclaimer
Disclaimer For personal use only SCOPE & LIMITATIONS This Presentation has been prepared by Micro-X Limited (Micro-X or the Company) (ASX.MX1). The Presentation is a summary only and does not contain all the information about the Company’s assets and liabilities, financial position and performance,
Slide 16: Key Achievements for FY2020
Key Achievements for FY2020 For personal use only Micro-X is now in the commercialisation phase of its globally unique x-ray technology with increased product sales and expanded production capacity Demonstrated growth in Further insourcing of Advanced tube sales penetration: $3.8M proprietary techno
Slide 17: State-of-the-art, tube manufacturing facility
State-of-the-art, tube manufacturing facility For personal use only A video tour of our x-ray tube manufacturing facility is available on our website © Micro-X Ltd – Annual General Meeting - 18 November 2020 17
Slide 18: Technology Status
Technology Status For personal use only Growing acceptance that Cold-Cathode is the future of X-Ray Micro-X is first to market with a proven, Cold The goal is attractive, others are attempting to follow: 01 Cathode, Medical X-Ray product • Nanox in Israel • VEC Imaging in Germany with Varex in USA P
Slide 19: Our Strategy
Our Strategy For personal use only Monetise our ‘First Mover’ advantage Commercialise high in the value chain to maximise revenue – avoid commoditisation as long as possible – keep innovating to stay in front of competitors Look for the ‘low hanging fruit’ Expand channel partners & products where ou
Slide 20: Mobile DR: Nano Mobile X-ray for Healthcare
Mobile DR: Nano Mobile X-ray for Healthcare For personal use only Approved for sale in 40 countries – significant COVID-19 related sales demand $3.8m purchase orders in FY 2020 Bedside imaging – hospitals & temporary facilities Small & portable – 95kg compared to 350-600kg Approvals – FDA, CE Mark a
Slide 21: Mobile DR: Rover for Military & Remote Users
Mobile DR: Rover for Military & Remote Users For personal use only Strong military interest responding to their unmet need – FDA approved $1.4m Sales via WHO in Oct 2020 Rover is an adapted version of the Nano for the military • Deployed medical facilities treat injured military personnel • Higher p
Slide 22: Mobile DR: Expanding Rover Markets
Mobile DR: Expanding Rover Markets For personal use only The extreme mobility and low weight of Rover opens up possible new uses Point-of-Care x-ray imaging • Avoiding x-ray outpatient dept in hospitals • Door-to-door x-ray service with tele-radiology • Aged-care homes • Home visits Small-animal vet
Slide 23: IED Imaging Camera
IED Imaging Camera For personal use only Backscatter X-Ray Assessment of IEDs via robot • X-Ray ‘Camera’ takes images without separate detector– one sided viewing • Bomb disposal technicians face life threatening situation when placing conventional X-ray detector behind target • Australian Defence F
Slide 24: Breaking News: Imaging test success
Breaking News: Imaging test success For personal use only New Backscatter Imaging Approach confirmed for project - new architecture for IED Camera 10 second image 60 second image Resolving easily: Explosive material easily visible High Resolution Scan • Thin red wires 0.32mm diameter inside backpack
Slide 25: Breaking News: Major architecture change now adopted
Breaking News: Major architecture change now adopted For personal use only New Backscatter Imaging Approach – smaller, lighter, and faster with higher resolution, larger field-of-view, configurable design, faster to market, and lower development risk . New product COGS is 30% of previous Feature Pre
Slide 26: Airport Self-service Checkpoint
Airport Self-service Checkpoint For personal use only TSA funded ‘Checkpoint of the Future’ • Airport Checkpoint security • A blend of backscatter and transmission X-ray to provide three dimensional imaging of carry on luggage • Integrated body scanner and passport reader • Based on work Micro-X is
Slide 27: Brain imaging for strokes
Brain imaging for strokes For personal use only Point-of-care diagnosis inside the Golden Hour Brain Tomography for Stroke diagnosis New medical imaging technology for pre-hospital diagnosis of strokes in a mobile setting such as a road or air ambulance Curved detector will be the first of its kind
Slide 28: Established Capability: Manufacturing Operations
Established Capability: Manufacturing Operations For personal use only World-class manufacturing with efficiency learned from the automotive industry • State of the art manufacturing facility spanning over 2,000m2 • South Australian Tonsley Innovation District • ISO 13485 certified Quality Managemen
Slide 29: Established Capability: Engineering Design
Established Capability: Engineering Design For personal use only World-class capability in multi-disciplinary systems design • Customer-led design methodology; proven fast track development process • ISO13485 accredited design processes • 23 engineers and scientists covering: Mechanical & Materials;
Slide 30: Platform Technologies: Next Gen CNT X-ray
Platform Technologies: Next Gen CNT X-ray For personal use only Summit: Next generation mini-tube for multi-source applications – designed for mass production NUGGET MOSAIC FUGGLES SUMMIT Specification Value Specification Value Specification Value Specification Value Voltage Range 40kV – 110kV Volta
Slide 31: Platform Technologies: Image Processing
Platform Technologies: Image Processing For personal use only Image Reconstruction & Processing Backscatter Image Reconstruction and Display Core Property Imaging Software and Algorithms • Platform Imaging software leveraging unique properties of CNT x-ray tubes • Combines conventional x-ray 3D imag
Slide 32: Platform Technologies: High Voltage Supplies
Platform Technologies: High Voltage Supplies For personal use only In-house High Power generator project – central to all future x-ray tubes Objective: Complete in-house design & manufacture of high power generator by mid 2021 - reduce manufacturing costs and enable high-power Rover product for sale
Slide 33: Our Four Production Lines
Our Four Production Lines For personal use only Micro-X has a strategically planned product roll-out as our CNT technology is advanced Product First sales Addressable Market Mobile Bedside DR 2018 US$670M p.a. Backscatter Counter-IED 2022* US$1.8B USA: US$8B Airport Checkpoint 2024* RoW: US$16B Stro
Slide 34: Conclusion
Conclusion For personal use only Unlocking value from our revolutionary CNT technology • Own the proven technical edge • Products in market – with revenue • Multiple product lines in design • Massive addressable markets • Customer pull – not technology push • Demonstrated design & manufacturing capa
Slide 35: For personal use only
For personal use only Ltd ACN 153 273 735 Peter Rowland Managing Director 1284 South Road Tonsley SA 5042 +61 8 7099 3966 or +61 418 844 981 admin@micro-x.com micro-x.com
Slide 36: Question Time
Ordinary Business For personal use only Question Time Voting to Close Conclusion of Formal Business © Micro-X Ltd – Annual General Meeting - 18 November 2020 36